Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

America Great Health (AAGH)

Compare
0.0005
0.0000
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Loading Chart for AAGH
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0008 x --
  • Ask 0.0013 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0040
  • Volume 30,000
  • Avg. Volume 12,419
  • Market Cap (intraday) 10.601M
  • Beta (5Y Monthly) 5.12
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.

aaghus.com

5

Full Time Employees

June 30

Fiscal Year Ends

Recent News: AAGH

View More

Performance Overview: AAGH

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AAGH
400.00%
S&P 500 (^GSPC)
8.25%

1-Year Return

AAGH
84.76%
S&P 500 (^GSPC)
3.55%

3-Year Return

AAGH
99.23%
S&P 500 (^GSPC)
18.71%

5-Year Return

AAGH
90.91%
S&P 500 (^GSPC)
116.85%

Compare To: AAGH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AAGH

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    10.60M

  • Enterprise Value

    13.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    25.10

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    31.03

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -287.32%

  • Return on Assets (ttm)

    -167.07%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    420.99k

  • Net Income Avi to Common (ttm)

    -1.21M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.03k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    429.61k

Research Analysis: AAGH

View More

Company Insights: AAGH

Research Reports: AAGH

View More

People Also Watch